Program Goals cHL Overview cHL Poor Prognosis Risk Factors Case Study 1 45YearOld Man With EarlyStage cHL PostHDTASCT BV Maintenance Phase 3 AETHERA Trial Design Phase 3 AETHERA Trial Efficacy Data ID: 774739
Download Presentation The PPT/PDF document " Post-autologous Transplant Therapy for ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Post-autologous Transplant Therapy for Hodgkin Lymphoma
Slide2Slide3Program Goals
Slide4cHLOverview
Slide5cHLPoor Prognosis Risk Factors
Slide6Case Study 145-Year-Old Man With Early-Stage cHL
Slide7Post-HDT/ASCT BV MaintenancePhase 3 AETHERA Trial Design
Slide8Phase 3 AETHERA TrialEfficacy Data
Slide9Phase 3 AETHERA TrialSafety Data
Slide10Case Study 222-Year-Old Woman With Early-Stage cHL
Slide11Case Study 2Treatment Options
Slide12Case Study 343-Year-Old Woman With Bulky cHL
Slide13Case Study 3Treatment Options
Slide14Relapsed/Refractory cHLMoving Toward New Paradigm
Slide15Abbreviations
Slide16Abbreviations (cont)
Slide17References
Slide18References (cont)
Slide19References (cont)
Slide20References (cont)
Slide21References (cont)